NIH, industry and non-profits join forces to speed validation of disease targets
Goal is to develop new treatments earlier, beginning with Alzheimer's, type 2 diabetes, and autoimmune disorders.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: Alzheimer's | American Health | Autoimmune Disease | Diabetes | Diabetes Type 2 | Endocrinology | Health | National Institutes of Health (NIH)